Results 61 to 70 of about 25,204 (165)

Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result

Scientific Reports
Plasma epidermal growth factor receptor mutation (EGFRm) circulating tumor DNA (ctDNA) dynamics exhibit promise in predicting outcomes in patients with EGFRm-advanced non-small cell lung cancer (NSCLC).
Yaping Hong, Wu Zhuang, Jinhuo Lai, Haipeng Xu, Yueming He, Jinlan Lin, Qin Shi, Shengjia Chen, Zhangzhou Huang, Shijie Chen, Dongzhu Lu, Gen Lin, Yunjian Huang   +12 more
doaj   +1 more source

Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study

Molecular Oncology
Patients with gastro‐intestinal stromal tumors (GISTs) undergoing tyrosine kinase inhibitor therapy are monitored with regular computed tomography (CT) scans, exposing patients to cumulative radiation. This exploratory study aimed to evaluate circulating
Roos F. Bleckman, Charlotte M. S. C. Haag, Naomi Rifaela, Gerrieke Beukema, Ron H. J. Mathijssen, Neeltje Steeghs, Hans Gelderblom, Ingrid M. E. Desar, Arjen Cleven, Arja terElst, Ed Schuuring, Anna K. L. Reyners   +11 more
doaj   +1 more source

Multimodal Framework in Lung Cancer Management: Integrating Liquid Biopsy with Traditional Diagnostic Techniques

Cancer Management and Research
Wenlong Qi,1 Lin Tian,2 Jianan Xu,2 Zhenyu Li,2 Tan Wang2 1Changchun University of Traditional Chinese Medicine, Changchun, Jilin, 130000, People’s Republic of China; 2Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun,
Qi W, Tian L, Xu J, Li Z, Wang T
doaj  

Attitudes of cancer patients toward ctDNA-based liquid biopsy for follow-up. [PDF]

Mol Oncol
Chhajlani S, Mariën L, De Weerdt C, Wouters S, Teuwen LA, Prenen H, Janssens K, Vandamme T.   +7 more
europepmc   +1 more source

The utility of ctDNA in rectal cancer

The Oncologist
Gagandeep Brar, Pashtoon Murtaza Kasi
openaire   +2 more sources

Integration of Nanotechnology with ctDNA: New Advances for Monitoring Neoadjuvant Chemotherapy. [PDF]

Int J Nanomedicine
Wang Y, Kong J, Tian R.
europepmc   +1 more source

Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: A Multicenter Prospective Observational Study (COSMOS-MEL01). [PDF]

Cancer Res Commun
Namikawa K, Ogata D, Nakano E, Yamazaki N, Komada A, Takahashi A, Yoshikawa S, Notake C, Mitani R, Yoshino T, Nakamura Y.   +10 more
europepmc   +1 more source

Tumor-Free Circulating Tumor DNA in Node-Negative Rectal Cancers Undergoing Neoadjuvant Chemotherapy, Excision, and Observation in the Phase II NEO Trial (CO.28). [PDF]

JCO Precis Oncol
Loree JM, Titmuss E, Brown CJ, Rich T, Banks K, Gordon V, Patel S, Krahn M, Caycedo-Marulanda A, Raval M, Tu D, Jonker DJ, O'Callaghan CJ, Kennecke HF.   +13 more
europepmc   +1 more source

Liquid biopsy: a step forward in laboratory medicine

Advances in Laboratory Medicine
Díaz-Lagares Angel, Jiménez Wladimiro
doaj   +1 more source

ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6 [PDF]

Journal of Immunotherapy and Precision Oncology
Atlal Abusanad
doaj   +1 more source